NASDAQ:ACRS | Cash Flow Statement | Aclaris Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2013-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$21.51M
2026-03-31-$19.82M$102,000.00-$18.15M$13,000.00-$30.93M$57.78M
2025-12-31-$19.8M$102,000.00-$13.13M$24,000.00$10.37M-$2.53M
2025-09-30-$14.61M
2025-06-30-$15.43M
2025-03-31-$15.09M$128,000.00-$13.06M$43,000.00$19.12M-$275,000.00
2024-12-31-$96.55M$143,000.00-$8.94M$0.00-$88.72M$74.58M
2024-09-30-$7.59M
2024-06-30-$10.99M
2024-03-31-$16.94M$243,000.00-$20.82M$135,000.00$16.83M-$55,000.00
2023-12-31-$1.49M$228,000.00-$6.76M$441,000.00$7.55M$49,000.00
2023-09-30-$29.26M
2023-06-30-$29.57M
2023-03-31-$28.16M$198,000.00-$26.35M$553,000.00$25.8M
2022-12-31-$27.64M$190,000.00-$19.12M$105,000.00$2.7M$37,000.00
2022-09-30-$19.95M
2022-06-30-$20.53M
2022-03-31-$18.79M$208,000.00-$20.97M$164,000.00$29.93M$30,000.00
2021-12-31-$22.8M$197,000.00-$17.08M$200,000.00-$9.18M-$2,000.00
2021-09-30-$21.15M
2021-06-30-$18.16M
2021-03-31-$28.75M$288,000.00-$12.23M-$75.31M$100.75M
2020-12-31-$13.17M-$449,000.00-$8.86M$8,000.00-$2.31M$7.83M
2020-09-30-$10.66M
2020-06-30-$11.6M
2020-03-31-$15.59M$576,000.00-$6.81M$124,000.00$13.94M$10.92M
2019-12-31-$18.59M$320,000.00-$20.39M$266,000.00$56.44M-$30.01M
2019-09-30-$55.32M
2019-06-30-$49.88M
2019-03-31-$37.57M$2.23M-$31.32M$284,000.00$8.62M-$120,000.00
2018-12-31-$38.55M$958,000.00-$27.25M$146,000.00-$70.51M$128.18M
2018-09-30-$32.74M
2018-06-30-$31.22M
2018-03-31-$30.23M$222,000.00-$21.87M$298,000.00$56.19M$358,000.00
2017-12-31-$22.93M$181,000.00-$18.21M$577,000.00-$21.57M-$78,000.00
2017-09-30-$18.19M
2017-06-30-$14.84M
2017-03-31-$12.56M$50,000.00-$12.66M$195,000.00$5.96M$209,000.00
2016-12-31-$11.48M$40,000.00-$8.07M$62,000.00-$77.82M$98.27M
2016-09-30-$10.69M
2016-06-30-$12.87M
2016-03-31-$13.04M-$6.89M$40,000.00
2015-12-31-$4.71M-$4.14M$132,000.00
2015-09-30-$10.63M
2015-06-30-$2.59M
2015-03-31-$2.62M-$2.8M$77,000.00
2014-12-31-$2.6M-$2.76M$269,000.00
2014-09-30-$2.66M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$64.92M$454,000.00-$47.11M$111,000.00$48.37M-$5.86M
2024-12-31-$132.07M$807,000.00-$20.08M$121,000.00-$69.77M$74.54M
2023-12-31-$88.48M$863,000.00-$78.33M$1.31M$46.22M$26.71M
2022-12-31-$86.91M$797,000.00-$67.57M$605,000.00$12.63M$72.87M
2021-12-31-$90.87M$923,000.00-$52.13M$308,000.00-$167.63M$225.05M
2020-12-31-$51.02M$1.32M-$38.63M$453,000.00$6.39M$18.37M
2019-12-31-$161.35M$6.41M-$96.45M$1.61M$105.68M-$30.32M
2018-12-31-$132.74M$1.88M-$100.81M$1.36M$9.37M$128.26M
2017-12-31-$68.52M$402,000.00-$54.66M$1.24M-$55.69M$100.39M
2016-12-31-$48.08M$120,000.00-$34.6M$232,000.00-$61.9M$116.83M
2015-12-31-$20.56M$90,000.00-$20.37M$507,000.00-$76.95M$96.41M
2014-12-31-$8.52M-$7.64M$417,000.00
2013-12-31-$5.24M-$4.92M